Matthew D Linnik Net Worth & Insider Trades
Matthew D Linnik - CSO & Exec VP Research, La Jolla Pharmaceutical Co
What is Matthew D Linnik's Net Worth?
The current estimated net worth of La Jolla Pharmaceutical Co's CSO & Exec VP Research, Matthew D Linnik, is estimated to be about $22.48K . Matthew D Linnik owns about 1,300 units of La Jolla Pharmaceutical Co common stock. In the last 3 years at La Jolla Pharmaceutical Co, Matthew D Linnik has sold an estimated value of $60.84K worth.
What is Matthew D Linnik's Past Insider Trading?
Matthew D Linnik's largest sale order was 5,365 units , worth over $15.5K on December 27, 2006. In total, Matthew D Linnik has made about 10 transactions over 3 years of their time at La Jolla Pharmaceutical Co. Matthew D Linnik usually trades in December, with the busiest year in 2005 and 2006.
Matthew D Linnik
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What are La Jolla Pharmaceutical Co's Past Insider Trades?
La Jolla Pharmaceutical Co's most recent insider trade came on December 6, 2021 by David A Ramsay who bought 24,500 units worth $91.99K . In the last 18 years, insiders at La Jolla Pharmaceutical Co have sold an estimated value of $199.89M and bought an estimated value of $255.01M worth of shares. Insider trading is most common in May, with the busiest year in 2019. The most active traders at the company are Lakhmir Chawla, Chief Medical Officer, Michael Hearne, Chief Financial Officer, and James Rolke, Chief Scientific Officer .
LA JOLLA PHARMACEUTICAL CO Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||